<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03399032</url>
  </required_header>
  <id_info>
    <org_study_id>KE-0254/330/2017</org_study_id>
    <nct_id>NCT03399032</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Caspofungin</brief_title>
  <official_title>Pharmacokinetics of Caspofungin in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to describe the pharmacokinetics of standard doses of
      caspofungin in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective observational study performed on critically ill patients. Inclusion
      criteria are: severe sepsis on admission requiring broad-spectrum antibiotics. Both medical
      and surgical patients will be included. Any type of infections will be included (pulmonary,
      abdominal, urinary tract, etc.) Antibiotics regimen includes: broad spectrum anti-bacterial
      antibiotics plus caspofungin (70 mg i.v. on the first day day, and 50 mg i.v. on the
      consecutive days, once daily.

      Blood samples (3 mL) will be collected 2, 4, 8,12 and 24 hours after each dose of caspofungin
      for 3 consecutive days. The standard arterial canula will be used to obtain samples.

      30 minutes after each sample collection, blood will be centrifuged for 10 minutes at 3,000
      rpms. Subsequently, supernatant will be collected and frozen.

      Serum caspofungin concentration will be measured with high performance liquid chromatography.

      Each patient's hemodynamics parameters will be recorded with the use of transpulmonary
      thermodilution technique (PICCO). Other therapies i.e.: ventilatory support, sedation, an
      antifungal agent will be given as required.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 5, 2018</start_date>
  <completion_date type="Anticipated">September 3, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 6, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum concentration of caspofungin</measure>
    <time_frame>72 hours for each patient from the tigecycline treatment initiation</time_frame>
    <description>Samples obtain from ICU patients 2, 4, 8 12 and 24hours after each dose of caspofungin for 3 days.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Septic Shock</condition>
  <condition>Fungal Infection</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Caspofungin</arm_group_label>
    <description>Each patient will receive: caspofungin i.v. once daily ( 70 mg on the first day, 50 mg on the 2 and 3 day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caspofungin</intervention_name>
    <description>Each patient will receive: caspofungin i.v. once daily ( 70 mg on the first day, 50 mg on the 2 and 3 day
Blood samples (3 mL) will be collected 2, 4, 8, 12 and 24 hours after each dose of caspofungin for 3 consecutive days.</description>
    <arm_group_label>Caspofungin</arm_group_label>
    <other_name>blood collection</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Patients' arterial blood samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to ICU due to severer sepsis recognition. Both medical and surgical
        patients will be included. Any site of infection will be treated in the manner.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who require ICU treatment due to severe sepsis age

          -  18-80 years

          -  an eligible consent obtained from the patient or his/her attendant

        Exclusion Criteria:

          -  allergy to caspofungin

          -  lack of consent to participate in the study

          -  age of patients below 18 or above 80 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Michał Borys, M.D., PhD</last_name>
    <phone>+48 506350569</phone>
    <email>michalborys1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mirosław Czuczwar, M.D., PhD</last_name>
    <phone>+48 509390985</phone>
    <email>czuczwarm@gmail.com</email>
  </overall_contact_backup>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2018</study_first_posted>
  <last_update_submitted>January 7, 2018</last_update_submitted>
  <last_update_submitted_qc>January 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Michał Borys</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>caspofungin</keyword>
  <keyword>pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caspofungin</mesh_term>
    <mesh_term>Echinocandins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

